Skip to main content

Malik Fady Ibraham's Form 4 filing

Cytokinetics IncCYTK · filed Nov 18, 2026

Accession no.
0001061983-26-000114
Filed
Nov 18, 2026, 6:58 PM ET
Trade date
Nov 17, 2026
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $181.2K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Malik Fady IbrahamCIK 0001551778Officer (EVP Research & Development)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 17, 2026Common StockMOption exerciseAcquired+3,500$7.80+$27,300157,402Direct
Nov 17, 2026Common StockSSaleDisposed−3,300$51.73F1−$170,709154,102Direct
Nov 17, 2026Common StockSSaleDisposed−200$52.59F2−$10,518153,902Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 17, 2026Common StockMOption exerciseDisposed−3,500$0.00$09,386Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The reported transaction involves sale transactions from $51.39 to $52.37 per share. The weighted average price per share was $51.73. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F2

The reported transaction involves sale transactions from $52.52 to $52.66 per share. The weighted average price per share was $52.59. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)